Finally, Huntington National Bank lifted its stake in shares of Synopsys by 4,977.0% in the second quarter.

Source: https://www.dailypolitical.com/2023/12/15/baystate-wealth-management-llc-takes-position-in-synopsys-inc-nasdaqsnps.html

Huntington National Bank boosted its position in shares of Charles River Laboratories International by 53.7% during the 3rd quarter.

Source: https://www.etfdailynews.com/2023/05/06/charles-river-laboratories-international-inc-nysecrl-shares-sold-by-retirement-systems-of-alabama/

Huntington National Bank boosted its stake in Envestnet by 25.0% in the third quarter.

Source: https://www.americanbankingnews.com/2023/02/12/envestnet-inc-nyseenv-shares-bought-by-bessemer-group-inc.html

Huntington National Bank bought a new position in shares of GMS during the second quarter valued at $27,000.

Source: https://www.dailypolitical.com/2023/12/09/gms-inc-nysegms-given-average-recommendation-of-moderate-buy-by-brokerages.html

Huntington National Bank grew its stake in shares of Advanced Drainage Systems by 39.1% during the 3rd quarter.

Source: https://www.americanbankingnews.com/2023/05/19/advanced-drainage-systems-inc-nysewms-shares-bought-by-first-trust-advisors-lp.html

Huntington National Bank now owns 1,846 shares of the company’s stock worth $42,000 after purchasing an additional 730 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/03/13/alliancebernstein-l-p-increases-holdings-in-flywire-co-nasdaqflyw.html

Huntington National Bank now owns 189 shares of the medical research company’s stock valued at $37,000 after acquiring an additional 66 shares in the last quarter.

Source: https://www.etfdailynews.com/2023/03/21/charles-river-laboratories-international-inc-nysecrl-shares-bought-by-gradient-investments-llc/

Huntington National Bank now owns 313 shares of the company’s stock valued at $38,000 after purchasing an additional 263 shares during the last quarter.

Source: https://www.americanbankingnews.com/2023/10/28/polaris-inc-nysepii-expected-to-post-q4-2023-earnings-of-2-61-per-share.html

Huntington National Bank now owns 337 shares of the biotechnology company’s stock valued at $28,000 after acquiring an additional 187 shares in the last quarter.

Source: https://www.americanbankingnews.com/2023/12/13/300000-shares-in-bio-techne-co-nasdaqtech-acquired-by-broadcrest-asset-management-llc.html